FPMI

FluoroPharma Medical, Inc. FPMI

FPMI
FluoroPharma Medical, Inc. RBSH
Rebus Holdings, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc. EVLO
Evelo Biosciences, Inc. CMRA
Comera Life Sciences Holdings, Inc. SYVC
Synovics Pharmaceuticals, Inc. XENO
Xeno Transplants Corporation ANTH
Anthera Pharmaceuticals, Inc. NTII
Neurobiological Technologies, Inc. BBAL
New York Health Care, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode FPMI RBSH SNNAQ EVLO CMRA SYVC XENO ANTH NTII BBAL
6M 100.00 % 0.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 %
YTD 100.00 % -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 %
1Y 100.00 % 0.00 % 0.00 % 25.00 % -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 %
3Y -86.67 % -98.73 % 0.00 % -100.00 % -99.99 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 %
5Y -90.91 % -99.98 % -98.61 % -100.00 % -100.00 % 0.00 % -93.59 % -99.54 % -93.33 % -93.33 %
10Y -99.93 % -100.00 % -100.00 % -100.00 % -100.00 % 0.00 % -97.14 % -100.00 % -99.53 % -93.33 %
From the beginning -99.98 % -100.00 % -100.00 % -100.00 % -100.00 % 0.00 % -99.90 % -100.00 % -100.00 % -100.00 %

Dividend

Neurobiological Technologies, Inc.